- Open Access
Cardiac reflections and natural vibrations: Force-frequency relation recording system in the stress echo lab
Cardiovascular Ultrasound volume 5, Article number: 42 (2007)
The inherent ability of ventricular myocardium to increase its force of contraction in response to an increase in contraction frequency is known as the cardiac force-frequency relation (FFR). This relation can be easily obtained in the stress echo lab, where the force is computed as the systolic pressure/end-systolic volume index ratio, and measured for increasing heart rates during stress. Ideally, the noninvasive, imaging independent, objective assessment of FFR would greatly enhance its practical appeal.
1 – To evaluate the feasibility of the cardiac force measurement by a precordial cutaneous sensor. 2 – To build the curve of force variation as a function of the heart rate. 3 – To compare the standard stress echo results vs. this sensor operator-independent built FFR.
The transcutaneous force sensor was positioned in the precordial region in 88 consecutive patients referred for exercise, dipyridamole, or pacing stress. The force was measured as the myocardial vibrations amplitude in the isovolumic contraction period. FFR was computed as the curve of force variation as a function of heart rate. Standard echocardiographic FFR measurements were performed.
A consistent FFR was obtained in all patients. Both the sensor built and the echo built FFR identifiy pts with normal or abnormal contractile reserve. The best cut-off value of the sensor built FFR was 15.5 g * 10-3 (Sensitivity = 0.85, Specificity = 0.77). Sensor built FFR slope and shape mirror pressure/volume relation during stress. This approach is extendable to daily physiological exercise and could be potentially attractive in home monitoring systems.
The frequency-dependent control of transmembrane Ca2+ entry via voltage-gated Ca2+ channels provides cardiac cells with a highly sophisticated short-term system for the regulation of intracellular Ca2+ homeostasis . An increased stimulation rate increases the force of contraction: the explanation is repetitive Ca2+ entry with each depolarization and, hence, an accumulation of cytosolic calcium. This inherent ability of ventricular myocardium to increase its force of contraction in response to an increase in contraction frequency is known as the cardiac force-frequency relation (FFR) . Its assessment is still elusive for the clinical cardiologist, although several invasive and non-invasive methods have been proposed [3–6]. Among these methods, one exploits standard 2-D stress echocardiography and another heart vibrations changes detectable by an accelerometer, i.e. a device measuring mechanical vibrations generating heart sounds [7, 8]. Echocardiography uses artificially generated cardiac reflections; the accelerometer simply records naturally generated heart vibrations. With echocardiography the force is computed as the systolic pressure (SP)/end-systolic volume index (ESV) ratio [9–13]. It is important to evaluate not only the variation of force between rest and peak stress test, but also how the force varies with the increase of frequency. In fact, it is known that the FFR can be normal up-sloping or abnormal flat or biphasic, that is with an initial up-sloping followed by a later down-sloping trend [6, 14] (Figure 1).
Despite the advantages of a completely noninvasive approach, the technique enables therapy effectiveness and clinical status to be verified other than by time distance checks. Since FFR slope and shape are key determinants of clinical outcome in diseased hearts, [11–13, 15] FFR should be monitored with noninvasive operator-independent methods (Figure 2, 3, 4).
Aims of this study are: 1 – To evaluate the feasibility of the cardiac force measurement by a precordial cutaneous sensor 2 – To build the curve of force variation as a function of the heart rate during exercise, dipyridamole and pacing stress echocardiography. 3 – To compare the standard echocardiographic force-frequency relation measurements and hemodynamic assessment vs. this new sensor operator-independent built force-frequency relation.
We enrolled 88 consecutive patients (56 males, 62 ± 13 years) referred for stress echocardiography (49 for exercise, 31 for dipyridamole, 8 for pacing stress). The type of stress was clinically driven for exercise vs. dipyridamole, and by the presence of a permanent pace maker for pacing stress. The characteristics of the study patients are reported in Table 1. The local Ethical Committee approved the study protocol. All the patients gave their written informed consent before entering the study.
All patients met the following inclusion criteria: 1) referred to stress echo for clinically-driven testing; 2) acoustic window of acceptable quality; 3) willingness to enter the study. Exclusion criteria were: 1) unstable angina or recent myocardial infarction; 2) moderate-to-severe aortic stenosis; 3) hemodynamic instability, documentation of life-threatening ventricular arrhythmias (sustained ventricular tachycardia or ventricular fibrillation), atrial fibrillation. From the initially considered population of 92 patients, 4 were excluded for poor acoustic window (n = 2), or refusal to give written informed consent (n = 2).
Semi-supine bicycle exercise
Graded bicycle semi-supine exercise echo was performed in 49 patients starting at an initial workload of 25 watts lasting for 2 minutes; thereafter the workload was increased stepwise by 25 watts at 2 minutes interval. A 12-lead electrocardiogram and blood pressure determination were performed at baseline and every minute thereafter .
Dipyridamole stress echo
Contraindications of using dipyridamole were asthma, hypotension, bradyarrhythmias.
Pacing stress echo
The study population consisted of 8 patients with a permanent pace maker. The pacing protocol was accelerated (with a 10-beat increment every 60 s) until one of the following criteria was reached: 1 – 85% of maximal heart rate (age-corrected: 220 – age for men, 200 – age for women); or 2 – PM maximal programmable heart rate (which varied widely, according to the model of PM, up to 170 bpm during stress). Stimulation was performed, wherever possible, in atrial stimulation mode, or dual-chamber (DDD) pacing to have normal contraction sequence. In the VVI-implanted patients, ventricular stimulation mode was used .
Diagnostic end points and interruption criteria
The diagnostic end-points for all types of stress were: the development of obvious echocardiography positivity, obvious alterations of ECG (ST segment shift >3 mm). The exam was also stopped in case of limiting subjective side effects or hypertension (systolic pressure >220 mmHg, diastolic pressure >120 mmHg), hypotension (relative or absolute) with decrease of the blood pressure >30 mmHg, supraventricular arrhythmias (supraventricular tachycardia, atrial fibrillation), ventricular arrhythmias (ventricular tachycardia, frequent and polymorphous ventricular beats); limiting dyspnoea, or maximal predicted heart rate in the absence of ischemia .
All patients underwent transthoracic echocardiography at baseline and during stress.
Left ventricular end-diastolic and end-systolic volumes were measured from apical four- and two-chamber view, by an experienced observer using the biplane Simpson-method . Only representative cycles with optimal endocardial visualization were measured and the average of three measurements was taken. The endocardial border was traced, excluding the papillary muscles. The frame captured at the R wave of the ECG was considered to be the end-diastolic frame, and the frame with the smallest left ventricular cavity the end systolic frame. Images were acquired at baseline and at each increase in heart rate of 10 beats during stress.
Regional wall motion analysis
The Wall Motion Score Index (WMSI) was calculated in each patient at baseline and peak stress, according to the recommendations of the American Society of Echocardiography from 1 = normal-hyperkinetic to 4 = dyskinetic in a 17 segment model of the left ventricle [16, 19].
Blood pressure analysis
One nurse recorded blood pressures at rest and during each individual study. The blood pressure recording was made using a sphygmomanometer and the diaphragm of a standard stethoscope. Systolic and diastolic blood pressure was obtained in the right arm. During exercise test, blood pressure recording was obtained with patient lying in a left rotated semi supine position and instructed to hand grip to the left support with their left hand. Patients have been told to let their right hand go limp when blood pressure was measured.
End-systolic pressure-volume determination
In order to build the force-frequency relation, the force was determined at each step as the ratio of the systolic pressure (cuff sphygmomanometer)/end-systolic volume index (biplane Simpson rule/body surface area). At each heart rate step three cardiac cycles were analyzed and the ESV was calculated as the mean value. The FFR was built off line. The slope of the relationship was calculated as the SP/ESV (Systolic Pressure/End-Systolic Volume) index increase (Δ SP/ESV index from baseline to peak stress) (Figure 1 and Figure 5). The FFR was defined up-sloping when peak exercise SP/ESV index was higher than baseline and intermediate stress values; biphasic, with an initial up-sloping followed by a later down-sloping trend, when peak exercise systolic pressure/end-systolic volume index was lower than intermediate stress values [9–13]; flat or negative, when peak exercise systolic pressure/end-systolic volume index was equal to or lower than baseline stress values.
Arterial elastance and ventricular-arterial coupling
In all, ventricular arterial coupling was indexed by the ratio of left ventricular systolic elastance index (systolic pressure/end-systolic volume index) to arterial elastance (Ea, ratio of end-systolic pressure by stroke volume). Echocardiography (for ESV and stroke volume) and cuff sphygmomanometer (systolic pressure, multiplied x 0.90 to obtain end-systolic pressure) provided the raw measurements.
Because stroke volume (and input impedance) varies directly with body size, arterial elastance was adjusted for body surface area (EaI) to better reflect differences in arterial properties with age and between the genders adjusted for differences in body size [20, 21]. Of note ventricular-arterial coupling is ventricular elastance/arterial elastance, which can further be described as: end-systolic pressure/end-systolic LV volume divided by end-systolic pressure/stroke volume: the pressure terms in the numerator and the denominator cancel out, and ventricular-arterial coupling equals to stroke volume/end-systolic volume.
Systemic Vascular Resistance (SVR)
SVR were calculated according to the traditional formula:
where 5 is an approximation of the right atrial pressure and MAP is mean arterial pressure.
Systemic arterial compliance
Systemic arterial compliance (C) was calculated as stroke volume index/systemic arterial pulse pressure; where pulse pressure = systolic blood pressure - diastolic blood pressure .
The cardiac force measurement by the precordial cutaneous sensor and the operator-independent force-frequency relation
Isovolumic myocardium contractions generate vibrations which have audible components that are responsible for the first heart sound [7, 8]. These vibrations can be measured with modern accelerometer based technology. These devices are small in size and can be easily used to build a cutaneous sensor (Figure 2).
The transcutaneous force sensor is based on a linear accelerometer from STMicroelectronics (LIS3). The device includes in one single package a MEMS sensor that measures a capacitance variation in response to movement or inclination and a factory trimmed interface chip that converts the capacitance variations into analog signal proportional to the motion. The device has a full scale of ±2·g (g = 9.8 m/s2) with a resolution of 0.0005·g. We housed the device in a small case (Figure 3) which was positioned in the mid-sternal precordial region and was fastened by a solid gel ECG electrode. The acceleration signal was converted to digital and recorded by a laptop PC, together with an ECG signal. The system is also provided with a user interface that shows both the acceleration and the ECG signals while the acquisition is in progress. The data were analyzed by using software developed in Matlab (The MathWorks, Inc). A QRS detection algorithm was used to automatically locate the beginning of the isovolumic ventricular contractions . The amplitude of the vibration due to isovolumic myocardium contraction was then obtained to record systolic force for each cardiac beat [24, 25]. While echocardiography uses artificially generated cardiac reflections, the accelerometer simply records naturally generated heart vibrations, which audible components in the isovolumic (preejection) contraction period give rise to the first heart sound. Non myocardial noising vibrations (skeletal muscles, body movements, breathing) were eliminated by frequency filtering (Figure 4, 5).
The curve of force variation as a function of heart rate was finally computed as the increment with respect to the resting force value. All the parameters were acquired as instantaneous values at baseline and during stress; mobile mean was utilized to assess baseline value (1 minute recording), at each incremental stress test, at peak test, and during recovery. Baseline, peak stress, peak-rest difference as absolute value, and delta % rest-peak stress values were computed. The force-frequency relation was defined up-sloping when the peak stress force was higher than baseline and intermediate stress values; biphasic, with an initial up-sloping followed by a later down-sloping trend, when the peak stress force was lower than intermediate stress values; flat or negative, when the peak stress force was equal to or lower than baseline stress values [6, 14]. The critical heart rate (or optimum stimulation frequency) was defined as the heart rate at which the force reaches the maximum value during progressive increase in heart rate; in biphasic pattern, the critical heart rate is the heart rate beyond which the force has declined by 5%; in negative pattern the critical heart rate is the starting heart rate.
SPSS 11 for Windows was utilized for statistical analysis. The statistical analyses included descriptive statistics (frequency and percentage of categorical variables and mean and standard deviation of continuous variables). Pearson chi-square with Fisher's exact test for categorical variables and the Mann-Whitney test for continuous variables for inter-group comparisons were performed to confirm significance (using Monte Carlo method for small sample comparisons).
The one-way ANOVA was used to compare continuous variables between groups; when homogeneity of variance was not present, the Kruskal-Wallis test for nonparametric independent samples was used. Intergroup comparison was performed with Scheffe and Tamhane post hoc tests, respectively.
Relations between variables were assessed using linear regression analysis and Pearson's correlation coefficient.
Analysis of variance with Fisher's post hoc pair wise multiple comparisons was used to assess the significance of intragroup repeated measures. The best predictors of the sensor built force-frequency relation slope and shape were assessed. Receiver operator characteristic (ROC) curve analysis was used to determine potentially useful threshold values of the sensor built FFR as cut-off for normal vs. abnormal contractile reserve (as assessed by the standard echo method: Δ Peak-rest SP/ESV ≥ 4 vs. <4 in exercise, positive vs. negative FFR in Dipyridamole stress). Contingency tables were constructed to assess the sensitivity and the specificity of the new operator independent method to assess the normal threshold for contractile reserve.
Resting and stress echocardiographic findings
Technically adequate images were obtained in all patients at baseline (by selection) and during stress.
At Peak Exercise
Heart rate was lower in the dipyridamole than in the exercise and pacing groups. The mean ejection fraction increased in the exercise and Dip groups, while decreased in the pacing group. Regional wall motion abnormalities occurred in 4 patients of the exercise, 1 patient of Dip and 2 patients of the pacing groups (Table 2).
Contractile response to stress
SP/ESV index increased to 14.7 ± 8 mmHg/mL/m2 in the exercise, and in the pacing (to 10.3 ± 8.1 mmHg/mL/m2) group, although the response was heterogeneous at the individual level (Table 2). A representation of the behavior of a normal up sloping (Δ SP/ESV index, rest-peak, ≥4 mmHg/mL/m2) an abnormal flat or flat-biphasic (Δ SP/ESV index, rest-peak, <4 mmHg/mL/m2) force-frequency relationship is shown in Figure 6 for exercise and in Figure 7 for pacing. An abnormal flat biphasic FFR was present in 13/49 pts of exercise and in 4/8 pts of pacing group.
The normal FFR cutoff was lower in the dipyridamole group (normal, Δ SP/ESV index, rest-peak, ≥0 mmHg/mL/m2; abnormal = Δ SP/ESV index, rest-peak, <0 mmHg/mL/m2) due to the lower stress heart rate increase and to the milder catecholamine increase (Figure 8). An abnormal negative FFR was present in 9/31 pts of the Dip group.
Peripheral pressures, load and coupling
Arterial elastance increased in the exercise and the pacing groups, while decreased in the dipyridamole, mainly due to a greater dipyridamole induced arterial compliance (Table 2).
In the whole group of patients, peak stress diastolic blood pressure was >80 mmHg in 34 patients, ≤80 mmHg in 54 patients.
Despite similar baseline values, diastolic blood pressure increased in the exercise, decreased in the dipyridamole, while unchanged in the pacing group; although the response was heterogeneous at the individual level (Table 2). An exercise induced diastolic hypertensive response (DPB ≥ 105 mmHg) was present in 10/49 patients of the exercise group; 13/31 patients of the Dip group showed a pharmacological induced hypotensive (DBP <70 mmHg) response.
Sensor built force-frequency relation
A consistent isovolumic systolic force signal was obtained in all patients at rest and during stress (Fig. 4, 5). In the patients as a whole, baseline force amplitude was 10.8 ± 5.3 g * 10-3, increasing to 26.8 ± 18 g * 10-3 at peak stress; in the group of patients as a whole, the systolic force percentage increase from baseline to peak stress was significantly related to the percentage increase in heart rate (r = 0.63, p < 0.01).
The force increased from 10 ± 4.7 to 36 ± 18.7 g * 10-3 in the exercise, from 12.3 ± 6.1 to 15.3 ± 8.1 g * 10-3 in the dipyridamole group, and from 9.5 ± 4.5 to 15.2 ± 5.6 g * 10-3 in the pacing group.
Mean force percentage increase was + 275% in the exercise patients, + 28% in the dipyridamole patients and +74% in the eight pacing patients (p < 0.05 between groups) (Table 2).
In the exercise group the Δ rest-peak force was greater in the 9 control subjects than in the 40 patients (+ 45 ± 19 g * 10-3 vs. + 22 ± 13 g * 10-3, p < 0.01).
At linear regression analysis best determinants of the force amplitude changes during stress were the age of patients, the heart rate, and the contractility SP/ESV index, both as absolute rest-peak and as rest-peak % changes (Table 3).
Correlations between SP/ESV index changes and force changes are displayed in Figure 9. At ROC analysis the best cut-off value of the sensor built systolic force-frequency relation for normal vs. abnormal contractile reserve at exercise or pacing stress was Δ isovolumic systolic force = 15.5 g * 10-3 (Sensitivity = 0.85, Specificity = 0.77, Younden index = 1.62).
The best cut-off value for normal vs. abnormal contractile reserve at dipyridamole stress was Δ isovolumic systolic force = 0.35 g * 10-3 (Sensitivity = 0.8, Specificity = 0.71, Younden index = 1.51).
The sensor built force-frequency relation
A stable, reproducible, and consistent isovolumic systolic force signal was obtained in all patients. This high amplitude vibration is an expression of the tension wave front produced during initial activation of the heart in the isovolumic contraction phase . Baseline force value had an ample range (from 4 to 30 g * 10-3). Cardiac vibrations propagate as mechanical shear waves, and the intervening viscoelastic thoracic tissue attenuates the higher frequencies and introduces a variable propagation delay [26, 27]. The absolute force value in the single patient can be related to the transthoracic propagation of cardiac vibrations. In fact, when measured epicardially, preejection cardiac vibrations are up to 10 times more powerful than when measured on the chest. In our experimental model, changes of the isovolumic systolic force were linearly related to the echo SP/ESV index changes. Equally, normal vs. abnormal echo built FFR was identified by the sensor built FFR. Attempts have been made by other authors in animals and in humans to assess the usefulness of myocardial preejection vibration amplitude (which audible components give rise to the first heart sound) to quantify left ventricular contractility. Wood et al , studied the regional effects of myocardial ischemia on the epicardially recorded first heart sound in dogs, demonstrating that the amplitude of cardiac vibrations in the isovolumic systole are sensitive to global left ventricular contractility and independent of the site of application of the sensor (normal contracting or ischemic non-contracting area). Sakamoto et al  demonstrated that variations of the first heart sound amplitude are correlated to variations of the isovolumic maximum rise of LV pressure development (max. LV dP/dt).
However, to our knowledge, this is the first work in which the isovolumic systolic myocardial force vibration was utilized to build the force-frequency relation and in which, for the first time, a comparison with the echo built FFR has been made . Since FFR slope and shape are key determinants of clinical outcome in diseased hearts, [11–13] FFR should be extensively monitored with this novel noninvasive operator-independent method. For sake of clarity, the conceptual and methodological differences between the FFR and the sound sensor system are contrasted in Table 4.
FFR and different stress
The basic property of the force-frequency effect to progressively enhance myocardial contractility as heart rate increases is augmented at each level of increasing adrenergic stimulation as occurs in exercise by catecholamine spillover. The sensor built FFR fulfilled recording of this typical pattern, both as absolute values, and for the capability to distinguish normal vs. abnormal contractile reserve, as confirmed by the standard echo built FFR cut-off (Figure 6).
Dipyridamole has the well known coronary vasodilator effects mediated by the inhibition of adenosine cellular transport, eventually leading to extra cellular adenosine accumulation and steal phenomena . There is a mild catecholamine release that is responsible for the mild inotropic effect of the drug (Figure 8). Simultaneously, the "pure" heart rate dependent increase in contractility is blunted due to the low heart rates increase during dipyridamole stress. These data are consistent with our findings; where there was a more pronounced and prolonged increase in the force signal in the exercise group vs. Dip group (Table 2). Despite the low number of patients, the pacing group showed intermediate FFR slope between exercise and dipyridamole: catecholamine levels are generally unchanged during the increase in heart rate produced by pacing . Therefore, at least theoretically, pacemaker stress echo is more suitable to assess FFR rather than inotropic reserve.
Clinical implications and current diagnostic options
The assessment of force-frequency relationship is a theoretically robust approach for evaluating left ventricular contractility, which has been deployed clinically using invasive, complex and technically demanding methods [3–6]. Previously, we proposed a non-invasive echocardiographic method [9–13] to assess the changes in contractility during exercise echo. FFR recording is feasible with a single precordial sensor fastened by a standard solid gel ECG electrode, in a totally automatic, operator independent fashion. FFR recording with a non-invasive sensor offers a new chance to monitor indexes of LV systolic function, especially in failing hearts and/or exposed to drugs .
In diseased hearts the force-frequency relation is altered. As the heart fails, there is a change in the gene expression from the normal adult pattern to that of fetal life with an inversion of the normal positive slope of the force-frequency relation: systolic calcium release and diastolic calcium reuptake process is lowered at the basal state and, instead of accelerating for increasing heart rates, slows down . The force-frequency relation of these diseased hearts exhibits a flat or negative slope at contraction frequencies above about 100 bpm [14, 15] (Figure 10). The heart rate at which the contractile force begins to decline diminishes progressively for known pathologies such as ischemic cardiomyopathy, diabetic cardiomyopathy, mitral regurgitation and dilated cardiomyopathy. The optimum contraction rate, i.e. the rate corresponding to the strongest contractile force, varies for each pathology, for each different stage of the illness, and for each patient . Different therapies are known to treat chronic heart failure, however the response must be tailored to each patient. For example, therapy with beta blockers has proved effective in cardiomegaly regression and in improving the myocardial function in patients suffering from dilated cardiomyopathy, however patients do not respond uniformly to this therapy. The bradycardic action of beta blockers reduces the number of daily working phases of the heart in the negative part of the force-frequency relationship. As the flattening and the descending limb of the force-frequency curve appears at different frequencies in the different types of cardiac decompensation and in different patients, the effectiveness of the action of beta blockers is variable. To optimize chronic heart failure therapy, it therefore appears essential to identify in each patient the ascending part of the force-frequency curve and the specific rate which, when exceeded, initiates the flattening and the descending part, in order to optimize individual therapy for chronic heart failure . Monitoring the patient's conditions with this new sensor built FFR not only enables his condition to be verified in terms of identifying an abnormal situation not in itself critical but predictive of a future worsening of chronic heart failure, but also it enables the effectiveness of therapies and their influence on the patient's condition under conditions of normality to be verified  (Figure 11). As distribution of the daily activities of the patient is variable, during the day the patient experiences, depending on the activities normally performed, periods in which his force-frequency relationship is of positive slope and periods in which his force-frequency relationship is of negative slope or flat. Known check up systems do not enable therapy effectiveness to be verified other than by occasional checks on the patient under rest conditions. By monitoring in accordance with this new sensor, not only can positive or negative decompensation changes as a result of certain events be determined, but also the variation in the force-frequency curve over twenty-four hours, days or weeks can be evaluated. A three-dimensional diagram could be determined which for each heart rate not only indicates the instantaneous force value but also enables the variation of said value with time to be monitored. (Figure 12). If the curve of force variation at a determined heart rate during the course of the day is reproduced as a two-dimensional diagram, it gives a continuous indication of the progress of decompensation situations in response to the therapies adopted.
Limitations of the study
Heterogeneity of the study population
The patient's number and the incoming disease were different in the exercise, dipyridamole and pacing stress groups. Controls were present only in the exercise group: it isn't possible to have physiological and hemodynamic comparisons between stress groups. However, aim of this study, was not to assess physiological patterns and differences between type of stress, that are well known, but simply assess the feasibility of sensor isovolumic contraction force recording during stress echocardiography, and to compare the standard operator-dependent echo vs. this sensor operator-independent built force-frequency relation during stress.
Because only non-invasive measurements were available, systolic cuff pressure was used as a surrogate for end-systolic pressure. The non-invasive results tend to overestimate the actual ratio, in large part because the brachial arterial pressure reflects an amplified LV pressure wave secondary to the rheological properties of the arterial tree, and this difference may lead to overestimation of left ventricular pressure, specially if younger subjects are studied, in which blood pressure tends to be overestimated . However, the peak systolic pressure/end systolic volume ratio is a reproducible method of assessing left ventricular performance during exercise . Several experimental studies in animals  and in human beings  have shown that use of peak systolic pressure yielded nearly identical pressure-volume relations.
The estimation of the LV systolic elastance index by SP/ESV index assumes V0 = 0. The volume axis intercept of the end-systolic pressure/volume relationship V0 is generally lower in normal subjects than in CHF patients, and may also differ among DCM patients. Nevertheless, SP/ESV index is generally considered as a valid approximation of LV end systolic elastance . This may not hold true during exercise if V0 changes. It has been reported that V0 is not appreciably altered by inotropic stimulation  or changes in loading conditions: Maughan et al  showed that V0 changed by only 5 mL on average in response to changes in peripheral vascular resistances of 50 to 200% of normal; Little and Cheng  observed no significant change in V0 during treadmill exercise in dogs. It is likely, however, that V0 changes during exercise but this is impossible to assess at such levels of exercise in man.
Lack of comparisons with invasive measurements of force-frequency relation
Since end-systolic elastance (Ees), expressing the slope of the in-vivo, end-systolic ventricular pressure vs chamber volume relation, is the most "foolproof" window into in vivo myocardial contractility, Ees should be measured at each heart rate step increase, as made by Liu and coworkers . But measuring Ees for increasing heart rates is impractical: increasing heart rates obtained with temporarily pacing has to be adjunct to the LV conductance catheter, the LV pressure catheter, the vena cava balloon, and to afterload changes. However, at least cath lab animal studies should be done to validate the noninvasive, operator independent, sensor builded FFR.
Positive vs. negative contractile reserve and medications
Medication differences may have had an impact, blunting the force-frequency relation and the diastolic blood pressure. However, this variable could not be controlled for ethical and practical reasons. In addition, the index is relatively independent of afterload changes, since for a given level of contractility – blood pressure reduction should be accompanied by smaller end-systolic volume values.
Force-frequency recording is feasible with single precordial vibrations sensor connected to a standard ECG monitoring electrode and quantitatively documents left ventricular contractility changes in a totally automatic, operator independent fashion.
Sensor built force-frequency relation is strictly related to the standard stress echo built FFR. Echocardiography uses artificially generated cardiac reflections. The isovolumic systolic force sensor simply records naturally generated heart vibrations. The FFR is built on line. The system is portable, and the remote transmission of the FFR slope and shape is feasible and simple.
To establish fully the advantages and limits of this new method, comparisons with left ventricular pressure-volume loops in humans and multicenter study data are needed.
systemic arterial compliance
dilated ischemic cardiomyopathy
effective arterial elastance index
acceleration unit (9.8 m/sec2)
systemic vascular resistance
Piot C, Lemaire S, Albat B, Seguin J, Nargeot J, Richard S: High frequency-induced upregulation of human cardiac calcium currents. Circulation 1996, 93: 120-128.
Bowditch HP: Über die Eigenthüm-lichkeiten der Reizbarkeit, welche die Muskelfasern des Herzens zeigen. Ber Sächs Akad Wiss 1871, 23: 652-689.
Liu CP, Ting CT, Lawrence W, Maughan WL, Chang MS, Kass DA: Diminished contractile response to increased heart rate in intact human left ventricular hypertrophy: systolic versus diastolic determinants. Circulation 1993, 88: 1893-1906.
Hasenfuss G, Holubarsch C, Hermann HP, Astheimer K, Pieske B, Just H: Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. Eur Heart J 1994, 15: 164-170.
Bhargava V, Shabetai R, Mathiasen RA, Dalton N, Hunter JJ, Ross J Jr: Loss of adrenergic control of the force-frequency relation in heart failure secondary to idiopathic or ischemic cardiomyopathy. Am J Cardiol 1998, 81: 1130-1137. 10.1016/S0002-9149(98)00133-7
Inagaki M, Yokota M, Izawa H, Ishiki R, Nagata K, Iwase M, Yamada Y, Koide M, Sobue T: Impaired force-frequency relations in patients with hypertensive left ventricular hypertrophy. Circulation 1999, 14: 1822-1830.
Gemignani V, Bianchini E, Faita F, Giannoni M, Pasanini E, Picano E, Bombardini T: Operator-independent force-frequency relation monitoring during stress with a new transcutaneous cardiac force sensor. Proc 34th Annual Conference of Computers in Cardiology 2007.
Sakamoto T, Kusukawa R, Maccanon DM, Luisada AA: Hemodynamic determinants of the amplitude of the first heart sound. Circ Res 1965, 16: 45-47.
Bombardini T, Correia MJ, Cicerone C, Agricola E, Ripoli A, Picano E: Force-frequency Relationship in the Echocardiography Laboratory: A Noninvasive Assessment of Bowditch Treppe? J Am Soc Echocardiogr 2003, 16: 646-655. 10.1016/S0894-7317(03)00221-9
Bombardini T, Agrusta M, Natsvlishvili N, Solimene F, Pap R, Coltorti F, Varga A, Mottola G, Picano E: Noninvasive assessment of left ventricular contractility by pacemaker stress echocardiography. Eur J Heart Failure 2005, 2: 173-181. 10.1016/j.ejheart.2004.04.019
Grosu A, Bombardini T, Senni M, Duino V, Gori M, Picano E: End-systolic Pressure/Volume relations during dobutamine stress echo: a prognostically useful noninvasive index of left ventricular contractility. Eur Heart J 2005, 26: 2404-2412. 10.1093/eurheartj/ehi444
Bombardini T: Myocardial contractility in the echo lab: molecular, cellular and pathophysiological basis. Cardiovascular Ultrasound 3: 27. 2005, sep 8 10.1186/1476-7120-3-27
Bombardini T, Galderisi M, Agricola E, Coppola V, Mottola G, Picano E: Negative stress echo. Further prognostic stratification with assessment of pressare-volume relation. Int J Cardiol, in press. 2007 May 15
Mulieri LA, Hasenfuss G, Leavitt B, Allen PD, Alpert NR: Altered myocardial force-frequency relation in human heart failure. Circulation 1992, 85: 1743-1750.
Mulieri LA, Leavitt BJ, Martin BJ, Haeberle JR, Alpert NR: Myocardial force-frequency defect in mitral regurgitation heart failure is reversed by forskolin. Circulation 1993, 88: 2700-2704.
Armstrong WF, Pellikka PA, Ryan T, Crouse L, Zoghbi WA: Stress echocardiography: recommendations for performance and interpretations of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 1998, 11: 97-104. 10.1016/S0894-7317(98)70132-4
Picano E: Stress echocardiography. From pathophysiological toy to diagnostic tool. Circulation 1992, 85: 1604-12.
Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahan D, Schnittger I: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantification of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989, 2: 362-67.
Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS: American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002, 105: 539-42. 10.1161/hc0402.102975
Kass DA: Effective arterial elastance as index of arterial vascular load in humans. Circulation 1992, 86: 513-521.
Redfield MM, Jacobsen SJ, Borlaug BA, Rodeheffer RJ, Kass DA: Age- and gender-related ventricular-vascular stiffening. Circulation 2005, 112: 2254-2262. 10.1161/CIRCULATIONAHA.105.541078
Otsuki T, Maeda S, Iemitsu M, Saito Y, Tanimura Y, Ajisaka R, Miyauchi T: Contribution of systemic arterial compliance and systemic vascular resistance to effective arterial elastance changes during exercise in humans. Acta Physiol 2006, 188: 15-20. 10.1111/j.1748-1716.2006.01596.x
Opie LH: Mechanisms of cardiac contraction and relaxation. In Heart Disease. Volume Chap 19. 7th edition. Edited by: Braunwald E, Zipes DP, Libby P, Bonow RO. WB Saunders Company; 2005:457-489. page 480
Wood JC, Buda AJ, Barry DT: Time-frequency transforms: a new approach to first heart sound frequency dynamics. IEEE Trans Biomed Eng 1992, 39: 730-40. 10.1109/10.142648
Vermarien H: Mapping and vector analysis of heart vibration data obtained by multisite phono-cardiography. In Advances in cardiovascular physics. Edited by: Ghista DN, Ain A. Basel: Karger AG; 1989:135-85.
Zalter R, Hardy HC, Luisada AA: Acoustic transmission characteristics of the thorax. J Appl Physiol 1963, 18: 428-36.
Verburg J: Transmission of vibrations of the heart to the chest wall. In Advances in cardiovascular physics. Edited by: Ghista DN, Ain A. Basel: Karger AG; 1989:84-103.
Wood JC, Festen MP, Lim MJ, Buda AJ, Barry DT: Regional effects of myocardial ischemia on epicardially recorded canine first heart sound. J Appl Physiol 1994, 76: 291-302.
Suga H, Sagawa K, Shoukas AA: Load independence of the instantaneous pressure/volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio. Circulation Research 1973, 32: 314-322.
Ross J, Miura T, Kambayashi M, Eising GP, Ryu KH: Adrenergic control of the force-frequency relation. Circulation 1995, 92: 2327-2332.
Bombardini T: Method and device for the diagnosis and therapy of chronic heart failure. United States Patent 2005. US 6,859,662 B2
O'Rourke M, Kelly R, Avolio A: Mechanisms. In The arterial pulse. Edited by: O'Rourke M, Kelly R, Avolio A. Philadelphia: Lea & Febiger; 1992:121-28.
Mehmel HC, Stockins B, Ruffmann K, von Olshausen K, Schuler G, Kubler W: The linearity of the end systolic pressure volume relation in man and its sensitivity for the assessment of left ventricular function. Circulation 1981, 63: 1216-22.
Sekido M, Uemura R, Takayama M, Kiuchi K, Nejima J, Takano T: Left ventricular peak systolic pressure/end-systolic volume ratio change after dobutamine infusion for predicting left ventricular contractile reserve: comparison with Emax. J Cardiol 2002,39(2):75-84.
Ginzton LE, Lasks MM, Brizendine M, Conant R, Mena I: Noninvasive measurement of the rest and exercise peak systolic pressure/end systolic volume ratio: a sensitive two-dimensional echocardiographic indicator of left ventricular function. J Am Coll Cardiol 1984, 4: 509-16.
Carabello B: Ratio of end-systolic stress to end-systolic volume: is it a useful clinical tool? J Am Coll Cardiol 1989, 14: 496-98. 10.1016/0735-1097(89)90207-6
Little W, Cheng C, Peterson T, Vinten-Johansen J: Responses of the left ventricular end-systolic pressure-volume relation in conscious dogs to a wide range of contractile state. Circulation 1988, 78: 736-45.
Maughan WL, Sunagawa K, Burkhoff D, Sagawa K: Effects of arterial impedance changes on the end-systolic pressurevolume relation. Circ Res 1984, 54: 595-602.
Little WC, Cheng CP: Effect of exercise on left ventricular-arterial coupling assessed in the pressure-volume plane. Am J Physiol 1993, 264: H1629-33.
T.B. conceived this study, performed the data analysis, and drafted the manuscript; L.V., C.P., E.Pa., L.P. and M.P. were responsible for data collection and revised the manuscript; V.G., E.B., F.F. and M.G. were responsible for technology development and digital signal processing ; E.Pi. gave a contribution to preparation of study design, data discussion, and critical revision of the manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Bombardini, T., Gemignani, V., Bianchini, E. et al. Cardiac reflections and natural vibrations: Force-frequency relation recording system in the stress echo lab. Cardiovasc Ultrasound 5, 42 (2007). https://doi.org/10.1186/1476-7120-5-42
- Heart Sound
- Arterial Elastance
- Dipyridamole Stress
- Isovolumic Contraction